Cite
Nuclear factor-kappa B in the liver of patients with chronic hepatitis C: decreased RelA expression is associated with enhanced fibrosis progression
MLA
Boya, P.(Patricia), et al. Nuclear Factor-Kappa B in the Liver of Patients with Chronic Hepatitis C: Decreased RelA Expression Is Associated with Enhanced Fibrosis Progression. Jan. 2001. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..15311b2f77a9b4b5b730f0f12227d074&authtype=sso&custid=ns315887.
APA
Boya, P. (Patricia), Larrea, E. (Esther), Sola, J. (Josu), Majano, P. L. (Pedro L., Jimenez, C. (Carlos), Civeira, M. P. (María P., & Prieto, J. (Jesús). (2001). Nuclear factor-kappa B in the liver of patients with chronic hepatitis C: decreased RelA expression is associated with enhanced fibrosis progression.
Chicago
Boya, P. (Patricia), E. (Esther) Larrea, J. (Josu) Sola, P.L. (Pedro Lorenzo) Majano, C. (Carlos) Jimenez, M.P. (María Pilar) Civeira, and J. (Jesús) Prieto. 2001. “Nuclear Factor-Kappa B in the Liver of Patients with Chronic Hepatitis C: Decreased RelA Expression Is Associated with Enhanced Fibrosis Progression,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..15311b2f77a9b4b5b730f0f12227d074&authtype=sso&custid=ns315887.